Possible recurrence of desquamative interstitial pneumonitis in a single lung transplant recipient

36Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Idiopathic pulmonary fibrosis (cryptogenic fibrosing alveolitis) is a disorder with a very poor prognosis for patients who do not respond to therapy with corticosteroids alone or in combination with immunosuppressive drugs, e.g. cyclophosphamide or azathioprine. For patients with end-stage disease, lung transplantation remains the only possibility for long-term survival. We describe a patient who received a left single lung transplant for end-stage desquamative interstitial pneumonitis. One year later, the patient again began complaining of exertional dyspnoea and a gradual decline in the transfer factor of the lung for carbon monoxide (TL,CO) was apparent. A recurrence of the primary disease in the transplanted lung was suspected on transbronchial biopsies. During treatment with high doses of steroids, a Pneumocystis carinii pneumonia developed, which was treated with co- trimoxazole. The patient completely recovered and, after a period of over 2 yrs, remained in an excellent condition, after which time he was lost from follow-up.

Cite

CITATION STYLE

APA

Verleden, G. M., Sels, F., Van Raemdonck, D., Verbeken, E. K., Lerut, T., & Demedts, M. (1998). Possible recurrence of desquamative interstitial pneumonitis in a single lung transplant recipient. European Respiratory Journal, 11(4), 971–974. https://doi.org/10.1183/09031936.98.11040971

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free